Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Salmonella enterica serovar Typhi antigens are key molecular structures on the surface of the bacterium Salmonella Typhi, which causes typhoid fever. These include the O-antigen (somatic antigen), H-antigen (flagellar antigen), and Vi antigen (capsular polysaccharide antigen). These antigens play crucial roles in immune recognition, pathogenesis, diagnosis, and vaccine development by enabling the bacterium to evade host immunity and establish infection. Detection of antibodies against these antigens is used in diagnostic tests, and the Vi antigen is used in effective parenteral vaccines. Structural diversity and phase-variable modifications affect diagnostic accuracy and vaccine efficacy.
Vaccine-induced antibody production; diagnostic antigen detection
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Salmonella enterica serovar Typhi Antigens (S. Typhi Antigens).